Despite all of these statistics, there are still gaps in research and data. Novo Nordisk has worked with members of the diabetes community to identify and commission research to help fill these gaps and illuminate other areas of interest for advancing public policy. Novo Nordisk is proud to commission and conduct research that helps describe and measure the problems and challenges the U.S. faces in diabetes.
© 2016 Novo Nordisk All rights reserved. 0415-00026489-1 January 2016